Urologix, Inc.

Equities

ULGX

US9172731047

Advanced Medical Equipment & Technology

Market Closed - OTC Markets Other stock markets 09:48:12 2024-03-08 am EST			5-day change	1st Jan Change
0.0001 ^USD	+9,900.00%		-.--%	-.--%

2016	A unknown buyer acquired substantially all of the operating assets of Urologix, Inc.	CI
2015	Urologix Conducting A Strategic Review	CI

Urologix, Inc. Announces Preliminary Unaudited Revenue Results for the Third Quarter Ended March 31, 2014

April 10, 2014 at 05:00 pm EDT

Urologix, Inc. announced preliminary unaudited revenue results for the third quarter ended March 31, 2014. Third quarter fiscal year 2014 revenue totaled $3.4 million, down 12% compared to the second quarter of fiscal year 2014 and down 18% compared to the prior year's results.

Latest news about Urologix, Inc.

A unknown buyer acquired substantially all of the operating assets of Urologix, Inc.	16-02-01	CI
Urologix Conducting A Strategic Review	15-07-09	CI
Transcript : Urologix, Inc., Q3 2015 Earnings Call, May 12, 2015	15-05-12
Urologix, Inc. Reports Unaudited Earnings Results for the Third Quarter and Nine Months Ended March 31, 2015	15-05-12	CI
Urologix, Inc. Appoints Scott M. Madson as Chief Financial Officer Effective April 1, 2015	15-03-23	CI
Urologix, Inc. Reports Unaudited Earnings Results for the Second Quarter and Six Months Ended December 31, 2014	15-02-05	CI
Transcript : Urologix, Inc., Q2 2015 Earnings Call, Feb 05, 2015	15-02-05
Urologix, Inc. Announces Revenue Guidance for Second Quarter Ended on December 31, 2014	15-01-12	CI
Transcript : Urologix, Inc., Q1 2015 Earnings Call, Nov 04, 2014	14-11-04
Urologix, Inc. Reports Unaudited Earnings Results for the First Quarter Ended September 30, 2014; Provides Cash Flow Guidance for the Fiscal 2015	14-11-04	CI
Transcript : Urologix, Inc., Q4 2014 Earnings Call, Aug 19, 2014	14-08-19
Urologix, Inc. Announces Executive Changes	14-08-19	CI
Urologix, Inc. Reports Unaudited Earnings Results for the Fourth Quarter and Year Ended June 30, 2014; Reports Impairment of Goodwill for the Second Quarter Ended June 30, 2014; Provides Earnings Guidance for the Full Year 2015	14-08-19	CI
Urologix, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2014	14-05-28	CI
Transcript : Urologix, Inc., Q3 2014 Earnings Call, May 06, 2014	14-05-06
Urologix, Inc. Reports Unaudited Earnings Results for the Third Quarter and Nine Months Ended March 31, 2014	14-05-06	CI
Urologix, Inc. Announces Preliminary Unaudited Revenue Results for the Third Quarter Ended March 31, 2014	14-04-10	CI
Transcript : Urologix, Inc., Q2 2014 Earnings Call, Feb 04, 2014	14-02-04
Urologix Secures Extension of Credit Facility	14-02-04	CI
Urologix, Inc. Reports Unaudited Earnings Results for the Second Quarter and Six Months Ended December 31, 2013	14-02-04	CI
Urologix, Inc. Reports Revenue Results for the Second Quarter Ended December 31, 2013; Withdraws Previously Issued Fiscal Year 2014 Revenue Guidance	14-01-08	CI
Transcript : Urologix, Inc., Q1 2014 Earnings Call, Oct 29, 2013	13-10-29
Urologix, Inc. Announces Unaudited Earnings Results for the First Quarter Ended September 30, 2013; Reaffirms Revenue Guidance for Fiscal 2014	13-10-29	CI
Transcript : Urologix, Inc., Q4 2013 Earnings Call, Aug 20, 2013	13-08-20
Urologix, Inc. Reports Unaudited Earnings Results for the Fourth Quarter and Year Ended June 30, 2013; Provides Revenue Guidance for the Fiscal Year 2014; Reports Impairment Charges for the Fourth Quarter Ended June 30, 2013	13-08-20	CI

Chart Urologix, Inc.

Duration

Period

More charts

Company Profile

21st North Inc. is not engaged in any operating activity. The Company has dissolved.

Sector

Advanced Medical Equipment & Technology

More about the company

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
UROLOGIX, INC.	-.--%	2.13K
THERMO FISHER SCIENTIFIC	+8.33%	219B
DANAHER CORPORATION	+6.72%	183B
INTUITIVE SURGICAL, INC.	+10.18%	132B
BOSTON SCIENTIFIC CORPORATION	+24.91%	106B
SIEMENS HEALTHINEERS AG	-2.32%	62.09B
EDWARDS LIFESCIENCES CORPORATION	+10.56%	50.8B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+4.81%	50.88B
AGILENT TECHNOLOGIES, INC.	-0.24%	40.64B
GE HEALTHCARE TECHNOLOGIES INC.	+1.22%	35.71B

Other Advanced Medical Equipment & Technology